Please login to the form below

Not currently logged in
Email:
Password:

Incanthera appoints Laura Brogden as CFO

She joins from Summ.it

Drug development and targeted cancer medicines group Incanthera has appointed Laura Brogden as its new chief financial officer.

She said: “Having known the company for many years, I am thrilled to take the position at such a pivotal and exciting time, and I am very much looking forward to the plans ahead in the immediate future.”

With over 17 years’ industry experience, Brogen joins the University of Bradford spin-out from Summ.it, where she was responsible for a portfolio of entrepreneurial clients covering venture capital and private equity businesses.

Simon Ward, chief executive officer, Incanthera, said: “Laura is a fantastic addition to the Incanthera team, as someone well known to us through heading the finances for Incanthera at Summ.it, we are delighted that she has accepted the position within the company and the board.”

24th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics